Innocan Pharma Reports Financial Gains and Strategic Expansion Plans for H1 2025 Innocan Pharma has unveiled its financial results for the first half of 2025, highlighting increased operating profit and strategic expansion plans, despite market challenges.

Innocan Pharma Reports Financial Gains and Strategic Expansion Plans for H1 2025 #Israel #pharmaceuticals #CBD #Herzliya #Innocan

Innocan Pharma Reports Positive Findings on LPT-CBD in Göttingen Minipigs and Corporate Developments Innocan Pharma presents promising results for its LPT-CBD injection in minipigs, along with significant corporate updates including leadership changes.

Innocan Pharma Reports Positive Findings on LPT-CBD in Göttingen Minipigs and Corporate Developments #USA #Calgary #LPT-CBD #Innocan #CBD_Research